Concepedia

David W. Vredevoogd

DW

Statistics

Publications

14

Citations

1.1K

H-Index

14

Active since

2018

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Utrecht University

University of Amsterdam

Leiden University Medical Center

David W. Vredevoogd is an author at Oncode Institute specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

2018–2025

14

Publications

14

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg et al. · Cell · 2019 · 263 citations · Full text

, , +14

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman et al. · Nature Medicine · 2018 · 223 citations

, , +17

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman et al. · Nature Communications · 2020 · 123 citations · Full text

, , +17

A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool

Lianne Kok, Feline E. Dijkgraaf, Jos Urbanus et al. · The Journal of Experimental Medicine · 2020 · 114 citations · Full text

, , +17

Tissue patrol by resident memory CD8+ T cells in human skin

Feline E. Dijkgraaf, Tiago R. Matos, Mark Hoogenboezem et al. · Nature Immunology · 2019 · 86 citations · Full text

, , +16

1–5 of 14